Trials / Completed
CompletedNCT07104929
Beta Glucan 500 and Biological Age and Immune Age
Prospective Human Study Evaluating the Effects of Beta Glucan 500 on Markers of Biological Age and Immune Age: An Open-label Pilot Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- OvationLab · Network
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Beta Glucan | 12 weeks of supplementation with two capsules daily of BWH Labs Beta Glucan 500 |
Timeline
- Start date
- 2025-05-14
- Primary completion
- 2025-10-09
- Completion
- 2025-10-09
- First posted
- 2025-08-05
- Last updated
- 2026-02-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07104929. Inclusion in this directory is not an endorsement.